[VSsupport]

<img alt="" height="1" width="1" />Sucampo Announces Lubiprostone Data Presented At GASTRO 2009 UEGF/WCOGMedical News Today (press release)N=435) in patients with Irritable Bowel Syndrome with Constipation, the most common adverse reactions (incidence >4%) were nausea (8% vs. ...<nobr></nobr>

View the full article